Treatment of type 2 diabetes mellitus in elderly patients

被引：28

作者：

Gomez-Huelgas, R. ^{[1
,2
,3
,4
]}

Gomez Peralta, F. ^{[5
,6
]}

Rodriguez Manas, L. ^{[7
,8
,9
]}

Formiga, F. ^{[10
,11
]}

Puig Domingo, M. ^{[12
,13
,14
,15
]}

Mediavilla Bravo, J. J. ^{[16
,17
]}

Miranda, C. ^{[18
,19
]}

Ena, J. ^{[4
,20
]}

机构：

[1] Univ Malaga, Hosp Reg, Serv Med Interna, Malaga, Spain

[2] Inst Invest Biomed Malaga IBIMA, Malaga, Spain

[3] Inst Salud Carlos III, CIBER Obesidad & Nutr CIBEROBN, Madrid, Spain

[4] SEMI, Madrid, Spain

[5] Hosp Gen Segovia, Unidad Endocrinol & Nutr, Segovia, Spain

[6] SED, Madrid, Spain

[7] Hosp Univ Getafe, Serv Geriatria, Madrid, Spain

[8] Inst Salud Carlos III, CIBER Fragilidad & Envejecimiento Saludable CIBER, Madrid, Spain

[9] Soc Espanola Med Geriatr SEMEG, Madrid, Spain

[10] Hosp Univ Bellvitge, Unidad Geriatria, Barcelona, Spain

[11] SEGG, Madrid, Spain

[12] Hosp Badalona Germans Trias & Pujol, Serv Endocrinol & Nutr, Barcelona, Spain

[13] Inst Invest Ciencies Salut Germans Trias & Pujol, Barcelona, Spain

[14] Inst Salud Carlos III, CIBER Diabet & Enfermedades Metab Asociadas CIBER, Madrid, Spain

[15] SEEN, Madrid, Spain

[16] Ctr Salud Burgos Rural, Burgos, Spain

[17] Soc Espanola Med Gen SEMERGEN, Madrid, Spain

[18] Ctr Salud Buenavista, Toledo, Spain

[19] Soc Espanola Med Gen &Familia SEMG, Madrid, Spain

[20] Hosp Marina Baixa, Serv Med Interna, Alicante, Spain

来源：

REVISTA CLINICA ESPANOLA | 2018年 / 218卷 / 02期

关键词：

Type 2 diabetes mellitus; Elderly; Antidiabetic treatment; RANDOMIZED CLINICAL-TRIAL; BIPHASIC INSULIN ASPART; ONCE-WEEKLY DULAGLUTIDE; CHRONIC KIDNEY-DISEASE; FRAIL OLDER-ADULTS; DOUBLE-BLIND; GLYCEMIC CONTROL; CARDIOVASCULAR OUTCOMES; POOLED ANALYSIS; OPEN-LABEL;

D O I：

10.1016/j.rce.2017.12.003

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

The prevalence of type 2 diabetes mellitus (DM2) increases markedly with age. Anti diabetic treatment and the objectives of glycaemic control in elderly patients with DM2 should be individualised according to their biopsychosocial characteristics. In elderly patients for whom the benefits of intensive antidiabetic treatment are limited, the basic objectives should be to improve the quality of life, preserve functionality and avoid adverse effects, especially hypoglycaemia. Treatment of DM2 in the elderly was the subject of a consensus document published in 2012 and endorsed by several Spanish scientific societies. Since then, new therapeutic groups and evidence have emerged that warrant an update to this consensus document. The present document focuses on the therapeutic aspects of DM2 in elderly patients, understood as being older than 75 years or frail. (C) 2017 Elsevier Espana, S.L.U. and Sociedad Espanola de Medicina Interna (SEMI). All rights reserved.

引用

页码：74 / 88

页数：15

共 50 条

[1] Deintensification of Diabetes Treatment in Elderly Patients with Type 2 Diabetes Mellitus
Pirela, Daniela V.
Garg, Rajesh
DIABETES, 2019, 68
[2] Family environment and diabetes treatment in elderly patients with Type 2 diabetes mellitus
Furuhashi, N
Kuroda, M
Ishizawa, M
Takeda, N
Furuta, T
Yasuda, K
DIABETOLOGIA, 2002, 45 : A318 - A318
[3] Treatment of type 2 diabetes mellitus in the elderly
Yakaryilmaz, Funda Datli
Ozturk, Zeynel Abidin
WORLD JOURNAL OF DIABETES, 2017, 8 (06) : 278 - 285
[4] DE-INTENSIFICATION OF DIABETES TREATMENT IN ELDERLY PATIENTS WITH TYPE 2 DIABETES MELLITUS
Pirela, Daniela, V
Garg, Rajesh
ENDOCRINE PRACTICE, 2019, 25 (12) : 1317 - 1322
[5] Type 2 diabetes mellitus in elderly institutionalized patients
Cano Megias, M.
Guisado Vasco, P.
REVISTA CLINICA ESPANOLA, 2014, 214 (09): : 521 - 528
[6] Deprescription in elderly patients with type 2 diabetes mellitus
Silverii, Giovanni Antonio
Caldini, Eleonora
Dicembrini, Ilaria
Pieri, Maria
Monami, Matteo
Mannucci, Edoardo
DIABETES RESEARCH AND CLINICAL PRACTICE, 2020, 170
[7] Special considerations for treatment of type 2 diabetes mellitus in the elderly
Fravel, Michelle A.
McDanel, Deanna L.
Ross, Mary B.
Moores, Kevin G.
Starry, Mary J.
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2011, 68 (06) : 500 - 509
[8] Treatment of type 2 diabetes mellitus in the elderly - Special considerations
Gado, Klara
Tabak, GY. Adam
Vingender, Istvan
Domjan, Gyula
Dornyei, Gabriella
PHYSIOLOGY INTERNATIONAL, 2024, 111 (02) : 143 - 164
[9] Pathogenesis and comprehensive treatment strategies of sarcopenia in elderly patients with type 2 diabetes mellitus
Hou, Yang
Xiang, Jia
Wang, Bo
Duan, Shoufeng
Song, Rouxuan
Zhou, Wenhu
Tan, Songwen
He, Binsheng
FRONTIERS IN ENDOCRINOLOGY, 2024, 14
[10] The efficacy and safety of acarbose in the treatment of type 2 diabetes mellitus in elderly patients.
Chiasson, JL
Josse, RG
Dorman, JM
Gerstein, HC
Lau, D
Leiter, LA
Maheux, P
Meneilly, GS
Murphy, L
Rodger, NW
Ross, SA
Ryan, E
Yale, JF
Wolever, TMS
Haller, T
Elias, I
DIABETOLOGIA, 1999, 42 : A223 - A223

← 1 2 3 4 5 →